131 related articles for article (PubMed ID: 18669518)
1. Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in Escherichia coli with CTX-M phenotypes.
Donaldson H; McCalmont M; Livermore DM; Rooney PJ; Ong G; McHenry E; Campbell R; McMullan R
J Antimicrob Chemother; 2008 Nov; 62(5):1015-7. PubMed ID: 18669518
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods.
Nyberg SD; Meurman O; Jalava J; Rantakokko-Jalava K
Scand J Infect Dis; 2008; 40(5):355-62. PubMed ID: 17934979
[TBL] [Abstract][Full Text] [Related]
3. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
4. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
5. [Comparative assessment of the Vitek 2 and Phoenix systems for detection of extended-spectrum beta-lactamases].
Treviño M; Martínez-Lamas L; Romero-Jung P; Varón C; Moldes L; García-Riestra C; Regueiro BJ
Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):566-70. PubMed ID: 19473732
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
Jang W; Park YJ; Park KG; Yu J
J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Vitek-2 extended-spectrum beta-lactamase test against non-duplicate strains of Enterobacteriaceae producing a broad diversity of well-characterised beta-lactamases.
Robin F; Delmas J; Schweitzer C; Bonnet R
Clin Microbiol Infect; 2008 Feb; 14(2):148-54. PubMed ID: 18076663
[TBL] [Abstract][Full Text] [Related]
8. Laboratory diagnosis of bloodstream infections caused by extended-spectrum beta-lactamase-producing E. coli and Klebsiella species.
Skippen I; Shemko M; Palmer C; Shetty N
Br J Biomed Sci; 2006; 63(1):1-4. PubMed ID: 16613133
[TBL] [Abstract][Full Text] [Related]
9. Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.
Färber J; Moder KA; Layer F; Tammer I; König W; König B
J Clin Microbiol; 2008 Nov; 46(11):3721-7. PubMed ID: 18845821
[TBL] [Abstract][Full Text] [Related]
10. Can we rely on one laboratory test in detection of extended-spectrum beta-lactamases among Enterobacteriaceae? An evaluation of the Vitek 2 system and comparison with four other detection methods in Kuwait.
Dashti AA; Jadaon MM; Habeeb FM
J Clin Pathol; 2009 Aug; 62(8):739-42. PubMed ID: 19406738
[TBL] [Abstract][Full Text] [Related]
11. Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains.
Dashti AA; West P; Paton R; Amyes SGB
J Med Microbiol; 2006 Apr; 55(Pt 4):417-421. PubMed ID: 16533989
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases.
Thomson KS; Cornish NE; Hong SG; Hemrick K; Herdt C; Moland ES
J Clin Microbiol; 2007 Aug; 45(8):2380-4. PubMed ID: 17596369
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods.
Valenza G; Müller S; Schmitt C; Turnwald D; Lam TT; Frosch M; Abele-Horn M; Pfeifer Y
Eur J Clin Microbiol Infect Dis; 2011 Jul; 30(7):869-72. PubMed ID: 21271268
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.
Blanc V; Leflon-Guibout V; Blanco J; Haenni M; Madec JY; Rafignon G; Bruno P; Mora A; Lopez C; Dahbi G; Dunais B; Anastay M; Branger C; Moreau R; Pradier C; Nicolas-Chanoine MH
J Antimicrob Chemother; 2014 May; 69(5):1231-7. PubMed ID: 24402502
[TBL] [Abstract][Full Text] [Related]
16. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
17. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.
Woodford N; Ward ME; Kaufmann ME; Turton J; Fagan EJ; James D; Johnson AP; Pike R; Warner M; Cheasty T; Pearson A; Harry S; Leach JB; Loughrey A; Lowes JA; Warren RE; Livermore DM
J Antimicrob Chemother; 2004 Oct; 54(4):735-43. PubMed ID: 15347638
[TBL] [Abstract][Full Text] [Related]
18. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.
Rooney PJ; O'Leary MC; Loughrey AC; McCalmont M; Smyth B; Donaghy P; Badri M; Woodford N; Karisik E; Livermore DM
J Antimicrob Chemother; 2009 Sep; 64(3):635-41. PubMed ID: 19549667
[TBL] [Abstract][Full Text] [Related]
19. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
